Glioblastoma Clinical Trials in Miami, FL

View the best 10 glioblastoma medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Glioblastoma clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for glioblastoma in Miami, Florida

Michael Bask Gill, B Sc

Last Reviewed: December 22nd, 2024

Radiation Therapy

Radiation

Recruiting1 awardPhase 2

This trial studies how well dabrafenib and trametinib work after radiation therapy in children and young adults with a specific type of brain tumor. These drugs help stop tumor growth by blocking signals that tell the cells to multiply. Dabrafenib has been developed and tested extensively for a specific type of skin cancer, showing effectiveness both alone and when used with trametinib.

Girentuximab

Recruiting1 awardPhase 2

This trial will look at how well an imaging scan can detect and track cancer activity in people with solid tumors.

Selinexor +1 More

Selective Inhibitor of Nuclear Export

Recruiting1 awardPhase 1 & 2

This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.

Bevacizumab +1 More

Angiogenesis Inhibitor

Recruiting1 awardPhase 2

This trial is testing if adding nivolumab to radiation therapy and bevacizumab improves treatment for recurrent glioblastoma.

Intensity Modulated Proton Therapy (IMPT)

Proton Beam Therapy

Recruiting1 award

This trial is testing a new way to find and treat brain cancer using MRI scans and proton therapy. The hope is that this will kill more cancer cells with less side effects.

Berubicin +1 More

Anthracenedione

Recruiting1 awardPhase 2

This trial will compare the effect of two cancer drugs, berubicin and lomustine, on overall survival in patients with glioblastoma multiforme (GBM) who have failed standard first line therapy. A futility analysis will be performed after approximately 30-50% of planned patients have completed the primary endpoint at 6 months.

Exablate Model 4000

Focused Ultrasound

Recruiting1 award

This trial aims to test the safety and effectiveness of using the Exablate device to temporarily open the blood-brain barrier in patients with suspected Glioblastoma. By doing this, doctors can collect fluid from the brain to check for cancer cells. The study will take place at up to 25 centers in the US.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award

This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.

Optune®

Device

Recruiting1 award12 criteria

This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.

Ramipril

ACE Inhibitor

Recruiting1 awardPhase 2

This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.

Popular Filters

Trials With No Placebo

Selective Inhibitor of Nuclear Export

Selinexor + Temozolomide for Recurrent Glioblastoma

Recruiting1 awardPhase 1 & 2

Coral Gables, Florida

This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.

Focused Ultrasound

Focused Ultrasound BBBD for Glioblastoma

Recruiting1 award

Miami, Florida

This trial aims to test the safety and effectiveness of using the Exablate device to temporarily open the blood-brain barrier in patients with suspected Glioblastoma. By doing this, doctors can collect fluid from the brain to check for cancer cells. The study will take place at up to 25 centers in the US.

Proton Beam Therapy

Proton Therapy + Avastin for Recurrent Glioblastoma

Recruiting1 award

Miami, Florida

This trial is testing a new way to find and treat brain cancer using MRI scans and proton therapy. The hope is that this will kill more cancer cells with less side effects.

Small Molecule Inhibitor

BDTX-1535 + Temozolomide for Glioblastoma and Lung Cancer

Recruiting1 awardPhase 1 & 2

Miami, Florida

This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.

Virus Therapy

ERAS-801 for Glioblastoma

Recruiting1 awardPhase 1

Miami, Florida

This trial is testing ERAS-801, a new drug for treating brain cancer. It focuses on patients whose brain cancer has returned after treatment. The drug works by blocking signals that help cancer cells grow. Researchers want to find the safest and most effective dose of ERAS-801. ERAs may be useful for treating cancer patients.

Selective Inhibitors of Nuclear Export

Selinexor + Radiation for Brain Cancer

Recruiting1 awardPhase 1 & 2

Miami, Florida

This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.

View More Related Trials

Girentuximab

VBI-1901

Olaparib

APL-101

Bevacizumab

Dabrafenib +1 More

Radiation Therapy

Bevacizumab +1 More

Temozolomide +2 More

Radiation Therapy +4 More

Ramipril

Temozolomide +2 More

View more glioblastoma clinical trials miami

See more medical studies focusing on glioblastoma miami

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.